BioCentury
ARTICLE | Financial News

KaloBios completes IPO

February 4, 2013 8:00 AM UTC

KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. Business: Antibodies, Infectious, Inflammation Date completed: 1/31/13 Type: IPO Raised: $70 million Shares: 8.8 million Price:...